159152-22-4

Upstream product

• 5769-33-5 2,6-dimethyl-4-bromobenzaldehyde 
• 1066-54-2 trimethylsilylacetylene 
• 160682-01-9 2,6-dimethyl-4-iodobenzaldehyde 
• 70547-87-4 2,6-dimethyl-4-hydroxybenzaldehyde 
• 160682-00-8 2,6-dimethyl-4-iodobenzonitrile 

Downstream Products

• 184154-12-9 zinc(II) 5,15-bis(mesityl)-10-(4-iodophenyl)-20-[2,6-dimethyl-4-(2-(trimethylsilyl)ethynyl)phenyl]porphyrin 
• 159501-24-3 zinc(II) 5,10,15-tris[2,6-dimethoxyphenyl]-20-(2,6-dimethyl-4-(phenylethynyl)phenyl)porphyrin 

Relevant academic research and scientific papers

THYROMIMETICS

Compounds provided herein function as thyromimetics and have utility for treating diseases such as neurodegenerative disorders and fibrotic diseases. Pharmaceutical compositions containing such compounds are also provided, as are methods of their preparation.

Soluble synthetic multiporphyrin arrays. 1. Modular design and synthesis

A set of porphyrin building blocks has been developed for the construction of light-harvesting model compounds and related molecular photonic devices. The porphyrins are facially encumbered to enhance solubility in organic solvents, are employed in a defi

Porphyrin building blocks for modular construction of bioorganic model systems

We outline a modular building block strategy for the covalent assembly of porphyrin-containing model systems. Molecular design issues for the synthesis of porphyrin dimers, dye-porphyrin dyads, and multi-porphyrin arrays have been used to guide the develo